Central nervous system inhibition of pentagastrin-stimulated acid secretion by insulin-like growth factor II
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 42 (21) , 2091-2096
- https://doi.org/10.1016/0024-3205(88)90122-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Receptors for insulin-like growth factors and insulin on murine fetal cortical brain cellsBiochemical and Biophysical Research Communications, 1986
- Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: Relation to human somatomedins and insulinJournal of Supramolecular Structure and Cellular Biochemistry, 1981
- SomatomedinsNew England Journal of Medicine, 1980
- SomatomedinsNew England Journal of Medicine, 1980
- Effects of Insulin and of NSILA-S on the Perfused Rat Heart: Glucose Uptake, Lactate Production and Efflux of 3–0-Methyl GlucoseEuropean Journal of Clinical Investigation, 1975
- Effects of Human Somatomedin Preparations on Membrane Transport and Protein Synthesis in the Isolated Rat DiaphragmJournal of Clinical Endocrinology & Metabolism, 1974
- Human Somatomedin, the Growth Hormone-Dependent Sulfation Factor, Is Anti-LipolyticJournal of Clinical Endocrinology & Metabolism, 1972
- Somatomedin: Proposed Designation for Sulphation FactorNature, 1972
- A Serum Fraction with “Sulfation Factor Activity” Stimulatesin VitroIncorporation of Leucine and Sulfate Into Protein-Polysaccharide Complexes, Uridine Into RNA, and Thymidine Into DNA of Costal Cartilage from Hypophysectomized RatsEndocrinology, 1970
- Non-suppressible insulin-like activity of human serumBiochimica et Biophysica Acta (BBA) - General Subjects, 1966